MyBody-X angle on Gluten Labor

MyBody-X may offer tests related to gluten, but the scientific basis is often weak. Many commercial gluten sensitivity tests (e.g., IgG antibodies or stool markers) lack proper validation. Evidence for non-celiac gluten sensitivity (NCGS) is limited and relies mostly on self-reports, not objective biomarkers. A positive result does not necessarily indicate a clinically relevant disorder. Celiac disease requires specific diagnostic criteria (IgA-tTG, biopsy). MyBody-X should clearly state that such tests do not replace medical diagnosis. The evidence for most gluten lab tests is 'marketing' or 'unclear'. Caveat: Unnecessary dietary restrictions can lead to nutrient deficiencies. Consult a doctor for persistent symptoms.